IP Verse

Compositions For Treating Spinal Muscular Atrophy - EP3373972

The patent EP3373972 was granted to F Hoffmann LA Roche on Mar 20, 2024. The application was originally filed on Nov 8, 2016 under application number EP16794290A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3373972

F HOFFMANN LA ROCHE
Application Number
EP16794290A
Filing Date
Nov 8, 2016
Status
Granted And Under Opposition
Feb 16, 2024
Grant Date
Mar 20, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

DR SCHONDec 20, 2024DR SCHONADMISSIBLE

Patent Citations (13) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS2010099652
DESCRIPTIONWO2004082581
DESCRIPTIONWO2008142231
DESCRIPTIONWO2009151546
DESCRIPTIONWO2010019236
DESCRIPTIONWO2013119916
DESCRIPTIONWO2014209841
EXAMINATIONWO2013119916
INTERNATIONAL-SEARCH-REPORTFR2914188
INTERNATIONAL-SEARCH-REPORTWO2013112788
INTERNATIONAL-SEARCH-REPORTWO2015173181
OPPOSITIONWO2013119916
OPPOSITIONWO2015173181

Non-Patent Literature (NPL) Citations (6) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Aulton Michael E., Taylor Kevin M.G., "losage Form Design and Manufacture", Aulton’s Pharmaceutics The Design and Manufacture of Medicines, FOURTH EDITION, (20130101), pages 398 - 402-405, XP093254687-
OPPOSITION- D05: DECLARATION OF MR. PETER KÜHL DURING EXAMINATION OF US 16/685,431, DATED NOVEMBER 23, 2022-
OPPOSITION- D06: Declaration of Mr. Peter Kühl during examination of US 16/685,431, dated September 8, 2023-
OPPOSITION- Rowe Raymond C., Paul J Sheskey, Marian E Quinn, "Contents", Handbook of Pharmaceutical Excipients Sixth edition, Pharmaceutical Press, (20090101), pages 1 - 10, XP093254696-
OPPOSITION- Russman Barry S., "Spinal Muscular Atrophy: Clinical Classification and Disease Heterogeneity", JOURNAL OF CHILD NEUROLOGY., Decker, CA, CA , (20070801), vol. 22, no. 8, doi:10.1177/0883073807305673, ISSN 0883-0738, pages 946 - 951, XP093254681
OPPOSITION- Axente Mihaela et al, "Clinical features and genetics in non-5q spinal muscular atrophy caused by acid ceramidase deficiency", Journal of medicine and life, Carol Daila University Foundation, Romania, Romania , (20210601), vol. 14, no. 3, doi:10.25122/jml-2021-0147, ISSN 1844-122X, pages 424 - 428, XP093254682

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents